| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 02/20/2008 | EP1888512A2 Chemical compounds |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332612 Amorphous and crystalline forms of losartan potassium and process for their preparation |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/14/2008 | WO2008018843A1 Process for producing useful salts form of biphenyl-tetrazole compounds |
| 02/13/2008 | EP1885817A1 Responsive luminescent lanthanide complexes |
| 02/13/2008 | CN101121700A Organic sulfur-containing nitrogen-enriched compounds and preparing method thereof |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | CA2274132C Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 01/31/2008 | WO2008012852A1 Intermediate compounds for the preparation of angiotensin ii antagonists |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |
| 01/29/2008 | US7323483 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 01/29/2008 | US7323480 Diseases mediated by Peroxisome Proliferator-Activated Receptors such as glucose metabolism, lipid metabolism and insulin secretion, specifically Type 2 diabetes, hyperinsulemia, hyperlipidemia, hyperuricemia, hypercholesteremia, atherosclerosis, risk factors for cardiovascular disease, Syndrome X |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021027 Novel benzimidazole derivatives |
| 01/23/2008 | EP1879873A1 Neurotherapeutic azole compounds |
| 01/23/2008 | EP1464643B1 Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method |
| 01/23/2008 | CN100363353C Antifungal compound and its prepn process and application |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/17/2008 | WO2008007391A2 An improved process for the preparation of valsartan |
| 01/17/2008 | WO2008006875A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | WO2008006874A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | US20080015239 For glaucoma or ocular hypertension, irritable bowel disease, and maintenance of colonic mucous |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | CA2653698A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | CA2653697A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/16/2008 | EP1878729A1 Intermediate for the manufacture of valsartan |
| 01/16/2008 | EP1877389A1 Synthesis of cyclen derivatives |
| 01/16/2008 | CN100361994C Tetraphenyl porphyrin derivative and its application in organic electroluminescent device |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/10/2008 | WO2008004110A2 Process for the preparation of the angiotensin ii antagonist valsartan |
| 01/09/2008 | EP1874302A1 Angiotensin ii receptor antagonists |
| 01/09/2008 | EP1874301A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/09/2008 | EP1653950B1 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 01/09/2008 | EP1307237B9 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/09/2008 | CN101103018A Compounds for the treatment of CNS and amyloid associated diseases |
| 01/09/2008 | CN101103006A Process for preparing amorphous valsartan |
| 01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/03/2008 | WO2008000645A1 Tetrazole-substituted arylamides |
| 01/03/2008 | US20080004442 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 01/03/2008 | US20080004321 Potentiators of Glutamate Receptors |
| 01/03/2008 | US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death |
| 01/03/2008 | CA2654915A1 Tetrazole-substituted arylamides |
| 01/02/2008 | EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 01/01/2008 | US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase |
| 12/27/2007 | WO2007056219A3 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| 12/27/2007 | US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 12/27/2007 | US20070299064 Pesticidal Heterocyclic Dihaloallyl Compounds |
| 12/26/2007 | EP1868985A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 12/26/2007 | CN100357279C Process for the manufacture of valsartan |
| 12/25/2007 | US7312340 Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one |
| 12/25/2007 | US7312327 Method of preparing nitrogen macrocycles |
| 12/20/2007 | US20070293561 5-{3-[(1S,5S)-5-(3-Chloro-5-hydroxymethyl-phenoxymethyl)-4-oxo-cyclopent-2-enyl]-propyl}-thiophene-2-carboxylic acid; Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/19/2007 | CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 12/19/2007 | CN101088992A Cyclic arylamine as hole transferring material with high vitrification point and its synthesis process |
| 12/18/2007 | US7309792 Dimeric small molecule potentiators of apoptosis |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1864968A1 Complex compound and mri probe made of same |
| 12/11/2007 | US7307078 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 12/06/2007 | WO2007068894A3 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 12/05/2007 | EP1861093A2 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 12/05/2007 | EP1660463B1 A process for the preparation of phenyltetrazole derivatives |
| 12/05/2007 | CN101084201A Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 12/05/2007 | CN100352902C Metal ligand containing bleaching composition |
| 12/04/2007 | US7304093 Ketone compounds and compositions for cholesterol management and related uses |
| 11/29/2007 | WO2007134709A1 5-iodotetrazoles for use as antimycotic |
| 11/29/2007 | US20070276138 Modulators of peroxisome proliferator activated receptors |
| 11/28/2007 | EP1858863A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 11/28/2007 | EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof |
| 11/27/2007 | US7301028 Mitotic kinesin inhibitors |
| 11/27/2007 | US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 11/21/2007 | EP1546122B1 Process for the manufacture of valsartan |
| 11/20/2007 | US7297802 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides |
| 11/20/2007 | CA2139374C Polyaminated ligands and metal complexes thereof |
| 11/15/2007 | WO2007128874A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof |
| 11/15/2007 | WO2007128873A1 A method for the preparation of maleimido derivatives of biomolecule labeling reactants and conjugates derived thereof |
| 11/15/2007 | US20070265452 Method for Preparing 2-Alkoxy-5-Tetrazolyl-Benzaldehyde Compound |
| 11/15/2007 | US20070265323 Compounds for the treatment of metabolic disorders |
| 11/15/2007 | US20070265322 Compounds for the treatment of metabolic disorders |
| 11/15/2007 | CA2650952A1 Therapeutic compounds |
| 11/14/2007 | EP1853555A1 Anthranilic acid derivatives active at the hm74a receptor |
| 11/14/2007 | CN101070316A Di-aryl acid derivatives as ppar receptor ligands |
| 11/08/2007 | WO2007125585A1 Method for producing bitetrazolamine compound |